Clinical characteristics and survival outcome of patients with estrogen receptor low positive breast cancer
Open Access
- 9 March 2022
- journal article
- research article
- Published by Elsevier in The Breast
- Vol. 63, 24-28
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Borderline ER-Positive Primary Breast Cancer Gains No Significant Survival Benefit From Endocrine Therapy: A Systematic Review and Meta-AnalysisClinical Breast Cancer, 2018
- Divergent oestrogen receptor-specific breast cancer trends in Ireland (2004–2013): Amassing data from independent Western populations provide etiologic cluesEuropean Journal of Cancer, 2017
- Revisiting the definition of estrogen receptor positivity in HER2-negative primary breast cancerAnnals of Oncology, 2017
- The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer stagingCA: A Cancer Journal for Clinicians, 2017
- Estrogen Receptor Status and the Future Burden of Invasive and In Situ Breast Cancers in the United StatesJNCI: Journal of the National Cancer Institute, 2015
- Which threshold for ER positivity? a retrospective study based on 9639 patientsAnnals of Oncology, 2014
- Divergent estrogen receptor‐positive and ‐negative breast cancer trends and etiologic heterogeneity in DenmarkInternational Journal of Cancer, 2013
- Estrogen Receptor (ER) mRNA and ER-Related Gene Expression in Breast Cancers That Are 1% to 10% ER-Positive by ImmunohistochemistryJournal of Clinical Oncology, 2012
- Incidence of Breast Cancer in the United States: Current and Future TrendsJNCI: Journal of the National Cancer Institute, 2011
- Reduced risk of oestrogen receptor positive breast cancer among peri- and post-menopausal women in Scotland following a striking decrease in use of hormone replacement therapyEuropean Journal of Cancer, 2010